Montuerto, Jelly E.

HRN: 13-13-24  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/22/2025
06/29/2025
IV
500MG
Q8
Cholecystitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: